Indian-Led Study Warns of Rising Global Threat From Drug-Resistant Fungus Candida auris

An Indian-led scientific study has raised serious concerns about the growing global spread and increasing virulence of Candida auris, a highly drug-resistant fungal pathogen linked to high mortality rates even when patients receive treatment.

Researchers warn that the fungus, once considered rare, is rapidly evolving into a major international public health threat, particularly for hospitalised and immunocompromised patients. Its ability to resist multiple antifungal drugs, survive on surfaces, and evade the immune system makes containment especially difficult.

Health experts say the findings underscore the urgent need for stronger infection-control measures, better surveillance, and accelerated research into new antifungal therapies.

What Is Candida auris?

Candida auris is a multidrug-resistant fungus that causes severe invasive infections, most commonly in healthcare settings. First identified in 2009, it has since been reported across continents, prompting global health agencies to classify it as an emerging pathogen of high concern.

Unlike many other fungal infections, C. auris is difficult to identify using routine laboratory tests, often leading to delayed diagnosis and inappropriate treatment.

Where Does It Spread?

The fungus is primarily associated with hospitals, intensive care units, and long-term care facilities. It can persist for long periods on human skin, medical devices, and inanimate surfaces such as bed rails, monitors and hospital furniture.

Its resilience allows it to survive routine cleaning procedures, increasing the risk of outbreaks in healthcare environments.

Symptoms and Clinical Challenges

Infections caused by Candida auris can affect the bloodstream, wounds, ears and internal organs. Symptoms often resemble bacterial sepsis, making clinical detection challenging.

Common signs include:

• Persistent fever and chills

• Low blood pressure

• Rapid heart rate

• Bloodstream infections (candidemia) in severe cases

Because symptoms are non-specific, infections are frequently recognised late, worsening patient outcomes.

Why Is Candida auris So Dangerous?

Experts highlight several features that make the fungus particularly threatening:

• Multidrug resistance: Many strains are resistant to multiple classes of antifungal medications, severely limiting treatment options.

• High virulence: Mortality rates often exceed 50%, even among patients receiving antifungal therapy.

• Morphological flexibility: The fungus can shift from a yeast form to filament-like growth, helping it invade tissues.

• Immune evasion: It adapts rapidly to host immune responses and environmental stress, allowing it to persist despite treatment.

How Does It Transmit?

C. auris spreads mainly through direct contact with infected or colonised individuals, including those who show no symptoms. Transmission can also occur via contaminated surfaces, medical equipment, and invasive devices such as catheters and ventilators.

This silent spread makes routine screening and strict hygiene protocols critical in healthcare settings.

Why the Study Matters

The Indian-led research highlights that Candida auris is not only spreading geographically but also becoming more aggressive. Experts warn that without coordinated global action, the pathogen could overwhelm existing antifungal treatment strategies.

Public health specialists stress the need for:

• Enhanced hospital infection-control practices

• Rapid diagnostic tools

• Surveillance systems to track outbreaks

• Investment in new antifungal drug development

As antimicrobial resistance continues to rise worldwide, Candida auris represents a stark reminder that fungal pathogens — long overlooked compared to bacteria and viruses — pose a growing and deadly challenge to global health systems.